SW

Stephen E. Webber

AP Anadys Pharmaceuticals: 17 patents #1 of 73Top 2%
AP Agouron Pharmaceuticals: 17 patents #7 of 327Top 3%
ET Effector Therapeutics: 8 patents #5 of 24Top 25%
Hoffmann-La Roche: 4 patents #813 of 3,238Top 30%
OT Oncternal Therapeutics: 3 patents #7 of 22Top 35%
CL Cancer Research Campaign Technology Limited: 2 patents #30 of 134Top 25%
University Of Texas System: 2 patents #1,567 of 6,559Top 25%
AL Agresearch Limited: 1 patents #167 of 547Top 35%
UT University Of Texas: 1 patents #37 of 278Top 15%
Overall (All Time): #40,818 of 4,157,543Top 1%
58
Patents All Time

Issued Patents All Time

Showing 25 most recent of 58 patents

Patent #TitleCo-InventorsDate
12187759 TLR7 agonists James Appleman 2025-01-07
12037335 Substituted purines as TLR7 agonists James Appleman 2024-07-16
11952375 Crystalline forms of Mnk inhibitors Siegfried H. Reich, Paul A. Sprengeler, Alan X. Xiang, Justin T. Ernst, Bennett C. Borer +2 more 2024-04-09
11692005 TLR7 agonists James Appleman 2023-07-04
11130757 Crystalline forms of MNK inhibitors Siegfried H. Reich, Paul A. Sprengeler, Alan X. Xiang, Justin T. Ernst, Bennett C. Borer +2 more 2021-09-28
11059824 Substituted purines as TLR7 agonists James Appleman 2021-07-13
11014926 Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2 Paul A. Sprengeler, Siegfried H. Reich, Justin T. Ernst 2021-05-25
10711008 Indoline analogs and uses thereof 2020-07-14
10351569 Indoline analogs and uses thereof 2019-07-16
10227344 CK2 inhibitors, compositions and methods thereof Xueliang Tao, Elena Brin 2019-03-12
10112955 Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2 Paul A. Sprengeler, Siegfried H. Reich, Justin T. Ernst, Mike Shaghafi, Douglas E. Murphy +1 more 2018-10-30
10000487 Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers Paul A. Sprengeler, Seigfried H. Reich, Justin T. Ernst 2018-06-19
9822122 Indoline analogs and uses thereof 2017-11-21
9814718 MNK inhibitors and methods related thereto Siegfried H. Reich, Paul A. Sprengeler, Alan X. Xiang, Justin T. Ernst 2017-11-14
9669031 MNK inhibitors and methods related thereto Siegfried H. Reich, Paul A. Sprengeler, Alan X. Xiang, Justin T. Ernst 2017-06-06
9382248 Mnk inhibitors and methods related thereto Siegfried H. Reich, Paul A. Sprengeler, Alan X. Xiang, Justin T. Ernst 2016-07-05
8883758 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof Gregory J. Haley, Joseph R. Lennox, Alan X. Xiang, Erik J. Rueden 2014-11-11
8586578 Deuterated 5,6-dihydro-1H-pyridin-2-one compounds 2013-11-19
8129368 5,6-dihydro-1H-pyridin-2-one compounds Frank Ruebsam, Chinh Viet Tran, Douglas E. Murphy, Peggy A. Thompson, Peter Dragovich 2012-03-06
8097718 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof Gregory J. Haley, Joseph R. Lennox, Alan X. Xiang, Erik J. Rueden 2012-01-17
8097613 [1,2,4]thiadiazine 1,1-dioxide compounds Frank Ruebsam, Peter Dragovich, Douglas E. Murphy, Chinh Viet Tran 2012-01-17
7964724 Chiral cis-imidazolines Nader Fotouhi, Gregory J. Haley, Klaus Baek Simonsen, Binh Thanh Vu 2011-06-21
7943759 3-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereof Devron R. Averett, Joseph R. Lennox, Erik J. Rueden, David Louis Clark, Alan X. Xiang 2011-05-17
7842838 Pyrro[1,2-b]pyridazinone intermediates Frank Ruebsam, Martin Tran, Peter Dragovich, Liansheng Li, Douglas E. Murphy +3 more 2010-11-30
7781581 Process for the preparation of 5-amino-3H-thiazolo[4,5-d]pyrimidin-2-one Tingman Wang, John S. Ng 2010-08-24